Seminars in Diagnostic Pathology
Volume 23, Issue 2 , Pages 111-119 , May 2006

Gastrointestinal stromal tumors: Differential diagnosis

  • Nancy Dow, MD

      Affiliations

    • Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC
    • Corresponding Author InformationAddress reprint requests and correspondence: Nancy Dow, MD, Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, 6825 16th Street, N.W. Bldg, 54, Rm. 3003, Washington, DC 20306-6000.
    • ,
  • Georgeta Giblen, MD

      Affiliations

    • Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC
    • ,
  • Leslie H. Sobin, MD

      Affiliations

    • Division of Gastrointestinal Pathology, Armed Forces Institute of Pathology, Washington, DC
    • ,
  • Markku Miettinen, MD

      Affiliations

    • Division of Soft Tissue Pathology, Armed Forces Institute of Pathology, Washington, DC.

References 

  1. Miettinen M, Lasota J. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics. Pol J Pathol. 2003;54:3–24
  2. Lee JR, Joshi V, Griffin JW, et al. Gastrointestinal autonomic nerve tumor: immunohistochemical and molecular identity with gastrointestinal stromal tumor. Am J Surg Pathol. 2001;25:979–987
  3. Demetri G, van Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–480
  4. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004;28:889–894
  5. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005;29:52–68
  6. Miettinen M, Makhlouf HR, Sobin LH, et al. Gastrointestinal stromal tumors (GISTs) of the jejunum and ileum: a clinicopathologic, immunohistochemical and molecular genetic study of 906 cases prior to imatinib with long-term follow-up. Am J Surg Pathol. 2006;30:477–489
  7. Heinrich MC, Corless CL, Duensing A, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003;299:708–710
  8. Lasota J, Dansonka-Meiszkowska A, Sobin LH, et al. A great majority of GISTs with PDGFRA mutations represent gastric tumors with low or no malignant potential. Lab Invest. 2004;84:874–883
  9. Rossi G, Valli R, Bertolini F, et al. PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology. 2005;46:522–531
  10. Yi ES, Strong CR, Piao Z, et al. Epithelioid gastrointestinal stromal tumor with PDGFRA activating mutation and immunoreactivity. Appl Immunohistochem Mol Morphol. 2005;13:157–161
  11. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Esophageal stromal tumors: a clinicopathologic, immunohistochemical, and molecular genetic study of 17 cases and comparison with esophageal leiomyomas and leiomyosarcomas. Am J Surg Pathol. 2000;24:211–222
  12. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol. 2000;24:1339–1352
  13. Miettinen M, Sarlomo-Rikala M, Sobin LH. Mesenchymal tumors of the muscularis mucosae of colon and rectum are benign leiomyomas that should be separated from gastrointestinal stromal tumors: a clinicopathologic and immunohistochemical study of eighty-eight cases. Mod Pathol. 2001;14:950–956
  14. Miettinen M, Sobin LH, Sarlomo-Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT). Mod Pathol. 2000;13:1134–1142
  15. Paal E, Miettinen M. Retroperitoneal leiomyomas: a clinicopathologic and immunohistochemical study of 56 cases. Am J Surg Pathol. 2001;25:1355–1363
  16. Tavassoli FA, Norris HJ. Peritoneal leiomyomatosis (leiomyomatosis peritonealis disseminata): a clinicopathologic study of 20 cases with ultrastructural observations. Int J Gynecol Pathol. 1982;1:59–74
  17. Miettinen M, Furlong M, Sarlomo-Rikala M, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcomas in the rectum and anus (A clinicopathologic, immunohistochemical and molecular genetic study of 144 cases). Am J Surg Pathol. 2001;25:1121–1133
  18. Lasota J, Miettinen M. Leiomyosarcoma of the GI tract. Abstract Mod Pathol. 2005;18:65A
  19. Appelman HD, Helwig EM. Glomus tumor of the stomach. Cancer. 1969;23:203–213
  20. Miettinen M, Paal E, Lasota J, Sobin LH. Gastrointestinal glomus tumors: a clinicopathologic, immunohistochemical and molecular genetic study of 32 cases. Am J Surg Pathol. 2002;26:301–311
  21. Burke AP, Sobin LH, Shekitka KM, et al. Intra-abdominal fibromatosis (A pathologic analysis of 130 tumors with comparison of clinical subgroups). Am J Surg Pathol. 1990;14:335–341
  22. Yantiss RK, Spiro IJ, Compton CC, et al. Gastrointestinal stromal tumor versus intra-abdominal fibromatosis of the bowel wall: a clinically important differential diagnosis. Am J Surg Pathol. 2000;24:947–957
  23. Miettinen M. Are desmoid tumors kit positive?. Am J Surg Pathol. 2001;25:549–550
  24. Lucas DR, al-Abbadi M, Tabaczka P, et al. c-Kit expression in desmoid fibromatosis (Comparative immunohistochemical evaluation of two commercial antibodies). Am J Clin Pathol. 2003;119:339–345
  25. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998;11:728–734
  26. Monihan JM, Carr NJ, Sobin LH. CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses. Histopathology. 1994;25:469–473
  27. Montgomery E, Torbenson MS, Kaushal M, et al. Beta-catenin immunohistochemistry separates mesenteric fibromatosis from gastrointestinal stromal tumor and sclerosing mesenteritis. Am J Surg Pathol. 2002;26:1296–1301
  28. Makhlouf HR, Sobin LH. Inflammatory myofibroblastic tumors (inflammatory pseudotumors) if the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps?. Hum Pathol. 2002;33:307–315
  29. van de Rijn M, Hendrickson MR, Rouse RV. An immunohistochemical study of inflammatory fibroid polyps of the gastrointestinal tract. Appl Immunohistochem. 1994;2:54–59
  30. Hasegawa T, Yang P, Kagawa N, et al. CD34 expression by inflammatory fibroid polyps of the stomach. Mod Pathol. 1997;10:451–456
  31. Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol. 1998;15:102–110
  32. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol. 2000;157:377–384
  33. Emory TS, Monihan JM, Carr NJ, et al. Sclerosing mesenteritis, mesenteric panniculitis and mesenteric lipodystrophy: a single entity?. Am J Surg Pathol. 1997;21:392–398
  34. Guillou L, Fletcher JA, Fletcher CDM, et al. Extrapleural solitary fibrous tumour and hemangiopericytoma. In:  Fletcher CDM,  Unni KK,  Mertens F, et al. editor. Pathology and Genetics (Tumours of Soft Tissue and Bone). Lyon: IARC Press; 2002;p. 86–90
  35. Shidham VB, Chivukula M, Gupta D, et al. Immunohistochemical comparison of gastrointestinal stromal tumor and solitary fibrous tumor. Arch Pathol. 2002;126:1189–1192
  36. Taxy JB, Battifora H. Angiosarcoma of the gastrointestinal tract (A report of three cases). Cancer. 1988;62:210–216
  37. Usuda H, Naito M. Multicentric angiosarcoma of the gastrointestinal tract. Pathol Int. 1997;47:553–556
  38. Monihan JM, Meis-Kindblom JM, Kindblom L-G, et al. Angiosarcoma of the gastrointestinal tract: a study of 18 cases. [abstract] Mod Pathol. 1995;8:65
  39. Miettinen M, Sarlomo-Rikala M, Lasota J. KIT expression in angiosarcomas and fetal endothelial cells: lack of mutations of exon 11 and exon 17 of C-kit. Mod Pathol. 2000;13:536–541
  40. Shmookler BM. Retroperitoneal synovial sarcoma (A report of four cases). Am J Clin Pathol. 1982;77:686–691
  41. Hornick JL, Fletcher CD. Immunohistochemical staining for KIT (CD117) in soft tissue sarcomas is very limited in distribution. Am J Clin Pathol. 2002;117:188–193
  42. Barisella M, Andreola S, Rosai J. CD117 in soft tissue sarcomas. Am J Clin Pathol. 2002;118:470–471
  43. Tamborini E, Papini D, Mezzelani A, et al. c-KIT and c-KIT ligand (SCF) in synovial sarcoma (SS): an mRNA expression analysis in 23 cases. Br J Cancer. 2001;85:405–411
  44. Daimaru Y, Kido H, Hashimoto H, et al. Benign schwannoma of the gastrointestinal tract: a clinicopathologic and immunohistochemical study. Hum Pathol. 1988;19:257–264
  45. Miettinen M, Shekitka KM, Sobin LH. Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases. Am J Surg Pathol. 2001;25:846–855
  46. Scheithauer BW, Nora FE, Lechago J. Duodenal gangliocytic paraganglioma (Clinicopathologic and immunocytochemical study of 11 cases). Am J Clin Pathol. 1986;86:559–565
  47. Burke AP, Helwig EB. Gangliocytic paraganglioma. Am J Clin Pathol. 1989;92:1–9
  48. Tsuura Y, Hiraki H, Watanabe K, et al. Preferential localization of c-kit product in tissue mast cells, basal cells of skin, epithelial cells of breast, small cell lung carcinoma and seminoma/dysgerminoma in human: immunohisto-chemical study on formalin-fixed, paraffin-embedded tissues. Virchows Arch. 1994;424:135–141
  49. Montone KT, van Belle P, Elenitsas R, et al. Proto-oncogene c-kit expression in malignant melanoma: protein loss with tumor progression. Mod Pathol. 1997;10:939–944
  50. Ekfors TO, Kujari H, Isomaki M. Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) in the duodenum: the first visceral case. Histopathology. 1993;22:255–259
  51. Zambrano E, Reyes-Mugica M, Franchi A, et al. An osteoclast-rich tumor of the gastrointestinal tract with features resembling clear cell sarcoma of soft parts: reports of 6 cases of a GIST simulator. Int J Surg Pathol. 2003;11:75–81
  52. Antonescu CR, Nafa K, Dal Cin P, et al. EWS-CREB1: A recurrent variant fusion in celar cell sarcoma associated with gastrointestinal location and absence of melanocytic differentiation. Abstract Mod Pathol. 2006;19:8A
  53. Garcia J, Kramer MJ, Mackey Z, et al. Utility of CD117 immunoreactivity in differentiating metastatic melanoma from clear cell sarcoma. Abstract Mod Pathol. 2005;18:15A
  54. Maesawa C, Tamura G, Sawada H, et al. Angiomyolipoma arising in the colon. Am J Gastroenterol. 1996;91:1852–1854
  55. Makhlouf HR, Remotti HE, Ishak KG. Expression of KIT (CD117) in angiomyolipoma. Am J Surg Pathol. 2002;26:493–497
  56. Folpe AL, Mentzel T, Lehr HA, et al. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29:1558–1575
  57. Copie-Bergman C, Wotherspoon AC, Norton AJ, et al. True histiocytic lymphoma: a morphologic, immunohistochemical, and molecular genetic study of 13 cases. Am J Surg Pathol. 1998;22:1386–1392
  58. Hornick JL, Jaffe ES, Fletcher CD. Extranodal histiocytic sarcoma: clinicopathologic analysis of 14 cases of a rare epithelioid malignancy. Am J Surg Pathol. 2004;28:1133–1144
  59. Ricotti E, Fagioli F, Garelli E, et al. C-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cells. Blood. 1998;91:2397–2405
  60. Chen J, Yanuck RR, Abbondanzo SL, et al. c-Kit (CD117) reactivity in extramedullary myeloid tumor/granulocytic sarcoma. Arch Pathol Lab Med. 2001;125:1448–1452
  61. Valent P. 1995 Mack-Forster Award Lecture (Review Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes). Eur J Clin Invest. 1995;25:715–720
  62. Li WV, Kapadia SB, Sonmez-Alpan E, et al. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies. Mod Pathol. 1996;9:982–988
  63. Emerson RE, Ulbright TM. The use of immunohistochemistry in the differential diagnosis of tumors of the testis and paratestis. Semin Diagn Pathol. 2005;22:33–50
  64. Naeem M, Dahiya M, Clark JI, et al. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis. Hum Pathol. 2002;33:1182–1187
  65. Picken MM, Curry JL, Lindgren V, et al. Metanephric adenosarcoma in a young adult: morphologic, immunophenotypic, ultrastructural, and fluorescence in situ hybridization analyses: a case report and review of the literature. Am J Surg Pathol. 2001;25:1451–1457
  66. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13:205–220
  67. Dorfman DM, Bui MM, Tubbs RR, et al. The CD117 immunohistochemistry tissue microarray survey for quality assurance and interlaboratory comparison: collage of American Pathologists Cell Markers Committee Study. Arch Pathol Lab Med. 2006;130:779–782

 The opinions and assertions contained herein are the expressed views of the authors and are not to be construed as official or reflecting the views of the Departments of the Army or Defense.

PII: S0740-2570(06)00144-4

doi: 10.1053/j.semdp.2006.09.002

Seminars in Diagnostic Pathology
Volume 23, Issue 2 , Pages 111-119 , May 2006

Article Tools

* Image Usage & Resolution